Pharmacological preconditioning in global cerebral ischemia

Area of Science:

• Neuroscience
• Biochemistry
• Cell Biology

Background:

• Neuronal survival following transient global ischemia depends on new protein synthesis, particularly anti-apoptotic proteins.
• Bcl-2 protein is expressed in neurons that survive cerebral ischemia and its expression may correlate with ischemic tolerance.
• Chemical preconditioning using 3-nitropropionic acid (3-NPA) improves neuronal survival after global ischemia.

Purpose of the Study:

• To investigate whether changes in bcl-2 protein expression are involved in the induction of ischemic tolerance by 3-NPA.
• To examine the time course of bcl-2 protein expression following a single dose of 3-NPA.

Main Methods:

• Male Wistar rats were administered a single intraperitoneal dose of 3-NPA (20 mg/kg) or vehicle.
• Animals were observed at 3, 12, or 24 hours post-injection.
• Immunohistochemistry was used to compare bcl-2 immunoreactivity in the hippocampus and neocortex between treated and control groups.

Main Results:

• A single dose of 3-NPA significantly increased bcl-2 protein immunoreactivity in hippocampal neurons (CA1, CA3, CA4) and the neocortex in a time-dependent manner over 24 hours.
• Increased bcl-2 protein expression was observed in 4/5 or 5/5 animals in these regions (p < 0.025).
• Neuronal bcl-2 protein expression remained unchanged in CA2 and the dentate gyrus.

Conclusions:

• The findings suggest a potential role for bcl-2 protein in the chemical induction of ischemic tolerance mediated by 3-NPA.
• Increased bcl-2 protein may contribute to neuroprotection by controlling reactive oxygen species (ROS) bursts, protecting mitochondrial membranes, and inhibiting apoptosis.
• 3-NPA-induced bcl-2 expression might be initiated by increased ROS levels, as reported in other studies.